Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-02-07
2006-02-07
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S139100, C424S140100, C424S141100, C424S163100, C424S164100, C530S387100, C530S388100, C530S388400
Reexamination Certificate
active
06994854
ABSTRACT:
The subject of the invention is amino acid sequences of the AC-Hly fromB. pertussis, B. parapertussisand/orB. bronchiseptica, carrying epitopes capable of inducing a protective immune response against infection byBordetella. The subject of the invention is antibodies, especially monoclonal antibodies, directed against these epitopes.
REFERENCES:
patent: 5095094 (1992-03-01), Brezin et al.
patent: 5183745 (1993-02-01), Danchin et al.
patent: 5595901 (1997-01-01), Rocancourt et al.
patent: 0162639 (1985-11-01), None
patent: 0 235 474 (1987-09-01), None
patent: 0 275 689 (1988-07-01), None
patent: 0338 170 (1989-10-01), None
patent: 2 606 789 (1988-05-01), None
patent: WO 90/13312 (1990-11-01), None
Greenspan et al. (Nature Biotechnology 17: 936-937, 1999).
Campbell (Monoclonal Antibody Technology, Elsevier, N.Y. 1984; chapter 1, pp. 1-32).
Glaser et al (EMBO Journal, 1988, vol. 7, pp. 3997-4004).
Munier et al. (European Journal and Biochemistry, 1991, vol. 196, pp. 469-474).
Beattie et al., Repressor Binding to a Regulator Site in the DNA Coding Sequence is Sufficient to Confer Transcriptional Regulation of the virr-Repressed Genes (vrg Genes) inBordetella pertussis, Journal of Bacteriology, vol. 175, No. 2, pp. 519-527 (Jan. 1993).
Betsou, “Cyac-Mediated Activation is Important Not Only for Toxic but for Protective Activities ofBordetella pertussisAdenylate Cyclase-Hemolysin”,Infection and Imminity, vol. 61, No. 9, pp. 3583-3589 (sep. 1993).
Gross et al., “Targeted Mutation that Ablate Either the Adenylate Cylase or Hemolysin Function of the Bifunctional cyaA toxin ofBordetella pertussisAbolish Virulence”,Proc. Nat'l Acad. Sci., vol. 89, pp. 4898-4902 (Jun. 1992).
Hackett et al., “Internal Lysine Palmitoylation in Adenylate Cyclase Toxin fromBordetella pertussis”, Science, vol. pp. 433-435 (Oct. 1994).
Bartoloni et al.,Tokai J. Exp. Clin. Med., 13 (Suppl.), pp. 217-222 (1988).
Beattie et al., “A vir-Repressed Gene ofBordetella pertussisis Required for Virulence,”Infect.&Immun., vol. 60, No. 2, pp. 571-577 (1992).
Beattie et al.,J. Bacteriol., vol. 172, No. 12, pp. 6997-7004 (1990).
de Rossi et al.,Vet. Microbiol, vol. 56, pp. 65-77 (1997).
Goldman et al.,EMBO Journal, vol. 3, No. 6 1353-1356 (1984).
Grimprel et al.Clin.&Diagn. Lab. Immunol., vol. 3, No. 1, pp. 93-97 (1996).
Gueirard et al.,Scand. J. Immunol., No. 43, pp. 181-192 (1996).
Gueirard et al.,J. Clin. Microbiol., vol. 33, No. 8, pp. 2002-2006 (1995).
Gierard et al., IN: Bacterial Protein Toxins ed. Freer et al., pp. 152-153 (1994).
Gueirard et al., “Virulence of Bordetella bronchiseptica: Role of Adenylate Cyclase-Hemolysin,”Infect.&Immun., vol. 61, No. 10, pp. 4072-4078 (1993).
Guiso et al.,Microbiol. Pathogenesis, vol. 11, pp. 423-431 (1991).
Hausman et al.,Inf.&Imm., vol. 64, No. 10, pp. 4020-4026 (1996).
Horiguchi et al.,Inf.&Imm., vol. 59, No. 3, pp. 1112-1116 (1991).
Khelef et al.,Inf.&Imm., vol. 62, No. 7, pp. 2893-2900 (1994).
Khelef et al., IN: Bacterial Protein Toxins ed. Freer et al., pp. 514-515 (1994).
Khelef et al.,Microbiol. Pathogenesis, vol. 12, pp. 227-235 (1992).
Khelef et al.,Infection&Immunity, vol. 61, No. 2, pp. 486-490 (1993).
Knapp et al., “Two trans-Acting Regulatory Genes (vir and mod) Control Antigenic Modulatio inBordetella pertuss,” J. Bacteriol., vol. 170, No. 11, pp. 5059-5066 (1988).
LeBlay et al.,Microbiology, vol. 143, pp. 1433-1441 (1997).
Munoz et al.,Infection&Immunity, vol. 32, No. 1, pp. 243-250 (1981).
Nakase et al., “Bestandteile von Bordetella Pertussis. Besonders Über Die Schutzsubstanz,”Chem. Zentralblatt NR, 8-1284, p. 2576 (1966).
Pittman,Rev. Infectious Disease, vol. No. 3, pp. 401-412 (1979).
Glaser et al.,Molecular Microbiology, vol. 2, No. 1, pp. 19-30 (1988).
Novotny et al., “Adenylate Cyclase Activity of a 68,000-Molecular-Weight Protein Isolated from the Outer Membrane of Bordetella bronchiseptica”,Infection&Immunity, vol. 50, No. 1, pp. 199-206 (Oct. 1985).
Brennan et al., “Identification of a 69-Kilodalton Nonfimoral protein As an Aggulutinogen ofBordetella pertussis”,Infection&Immunity, vol. 56, No. 12, pp. 3189-3195 (Dec. 1988).
Charles et al., “Molecular cloning and characterization of protective outer membrane protein P.69 fromBordetella pertussis”, Proc. Nat'l Acad. Sci. USA, vol. 86, pp. 3554-3558 (May 1989).
Novotny et al., “Biologic and Protective Properties of the 69-kDa Outer Membrane Protein ofBordetella pertussis: A Novel Formulation for an Acellular Pertussis Vaccine”,J. Infectious Diseases, pp. 114-122 (1991).
S. Karger, Basel, “Bordetella Adenylate Cyclase: A Genus Specific Protective Antigen and Virulence Factor”, Proceedings of the Fourth International Symposium on Pertussis,Dev. Biol. Standard, vol. 61, pp. 27-41 (1985).
Kessin et al., “Secreted Adenylate Cyclase ofBordetella pertussis: Calmodulin Requirements and Partial Purification of Two Forms”,J. Bacteriology, pp. 290-296 (Apr. 1986).
Friedman, “Bordetella pertussisAdenylate Cyclase: Isolation and Purification by Calmodulin-Sepharose 4B Chromatography”,Infection&Immunity, pp. 129-134 (Jan. 1987).
Ladant et al., “Bordetella pertussisAdenylate Cyclase: Purification, Characterization and radioimmunoassy”,The Journal of Biological Chemistry, vol. 261, No. 34, pp. 16264-16269 (Dec. 1986).
Hewlett et al., “Adenylate Cyclase Toxin fromBordetella pertussisIdentification and Purification of Holotoxin Molecule”,The Journal of Biological Chemistry, vol. 264, No. 32, pp. 19379-19384 (Nov. 1989).
Shattuck et al., “Purification and Characterization of a Calmodulin-Sensitive Adenylate Cycle fromBordetella pertissis”, Biochemistry, vol. 24, pp. 6356-6362 (1985).
Hackett et al., “Hemolytic, but Not Cell-Invasive Activity, of Adenylate Cyclase Toxin Is Selectively Affected by Differential Fatty-acylation inEscherichia coil”, The Journal of Biological Chemistry, vol. 270, No. 35, pp. 20250-20253 (Sep. 1995).
Iwaki et al., “Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin”,Molecular Microbiology, vol. 17, No. 6, pp. 1015-1024 (1995).
Immunization Practices Advisory Committee, Clinical Pharmacy, col. 8, pp. 839-851 (1989).
Munier et al.,Eur. J. Biochem., vol. 196, No. 2, pp. 469-474 (1991).
Gross et al.,Proc. Nat'l. Acad. Sci. USA, vol. 89, No. 11, pp. 4898-4902 (1992).
Sakamoto et al.,J. Biological Chemistry, vol. 267, No. 19, pp. 13598-13602 (1992).
Heveker et al.,J. Biological Chemistry, vol. 269, No. 52, pp. 32844-32847 (1994).
Guiso et al., Proc. of the 6thInt'l. Symposium on Pertussis, pp. 207-211 (1990).
Guiso et al., Zentralblatt fur Bakteriologie, Supp. 23, pp. 268-271 (1992).
Ladant et al.,J. Biological Chemistry, vol. 264, No. 7, pp. 4015-4020 (1989).
Ladant et al.,J. Biological Chemistry, vol. 267, No. 4, pp. 2244-2250 (1992).
Ballalou et al.,Infection&Immunity, vol. 58, No. 10, pp. 3242-3247 (1990).
Peter Sobo et al., “Repeat Sequence in theBordetella pertussisAdenylate Cyclase Toxin Can Be Recognized as Alternative Carboxyproximal Secretion Signals by theEscherichia coliα-haemolysin translocator”,Molecular Microbiology, vol. 9, No. 5, pp. 999-1009 (1993).
Betsou et al., “The C-Terminal Domain is Essential for Protective Activity of theBordetella pertussisAdenylate Cyclase-Hemolysin,”Infection and Immunity, pp. 3309-3315 (1995).
Burnette et al., “Pertussis Toxin S1 Mutant with Reduced Enzyme Activity and a Conserved Protective Epitope,” Science, 242:72-74 (1988).
Tippetts et al., “Molecular Cloning and Expression of the Bacillus anthracis Ederna Factor Toxin Gene: a Calmodulin-Dependent Adenylate Cyclase,” J. Bacteriol. 170(5): 2263-2266 (1988).
Weiss et al., “Tn5-Induced Mutations Affecting Virulence Factors ofBordet
Betsou Fotini
Gutso Nicole
Sebo Peter
Finnegan Henderson Farabow Garrett & Dunner LLP
Institut Pasteur
Smith Lynette R. F.
Zeman Robert A.
LandOfFree
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly),... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protective epitopes of adenyl cyclase-haemolysin (AC-Hly),..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protective epitopes of adenyl cyclase-haemolysin (AC-Hly),... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3698894